Insider Trading Alert - PFE, WOOF And BOBE Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 18, 2014, 135 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $235.22 to $501,676,000.00.

Highlighted Stocks Traded by Insiders:

Pfizer (PFE) - FREE Research Report

Young John D who is Group President at Pfizer sold 9,000 shares at $31.38 on March 18, 2014. Following this transaction, the Group President owned 99,647 shares meaning that the stake was reduced by 8.28% with the 9,000-share transaction.

The shares most recently traded at $31.96, up $0.58, or 1.81% since the insider transaction. Historical insider transactions for Pfizer go as follows:

  • 4-Week # shares sold: 130,817
  • 12-Week # shares sold: 290,817
  • 24-Week # shares sold: 300,817

The average volume for Pfizer has been 25.4 million shares per day over the past 30 days. Pfizer has a market cap of $200.9 billion and is part of the health care sector and drugs industry. Shares are up 4.24% year-to-date as of the close of trading on Tuesday.

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. Its product portfolio includes medicines and vaccines, as well as various consumer healthcare products. The stock currently has a dividend yield of 3.31%. The company has a P/E ratio of 19.0. Currently there are 8 analysts that rate Pfizer a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PFE - FREE

TheStreet Quant Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, increase in stock price during the past year and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Pfizer Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

VCA Antech (WOOF) - FREE Research Report

Drake Josh who is President, Antech Diagnostics at VCA Antech sold 2,199 shares at $33.87 on March 18, 2014. Following this transaction, the President, Antech Diagnostics owned 65,277 shares meaning that the stake was reduced by 3.26% with the 2,199-share transaction.

The shares most recently traded at $34.26, up $0.39, or 1.13% since the insider transaction. Historical insider transactions for VCA Antech go as follows:

  • 4-Week # shares sold: 5,267
  • 12-Week # shares sold: 5,267
  • 24-Week # shares sold: 5,267

The average volume for VCA Antech has been 563,600 shares per day over the past 30 days. VCA Antech has a market cap of $3.0 billion and is part of the services sector and diversified services industry. Shares are up 9.15% year-to-date as of the close of trading on Tuesday.

VCA Antech, Inc. operates as an animal healthcare company in the United States and Canada. It operates through two segments, Animal Hospital and Laboratory. The company has a P/E ratio of 22.3. Currently there are 4 analysts that rate VCA Antech a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WOOF - FREE

TheStreet Quant Ratings rates VCA Antech as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full VCA Antech Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Bob Evans Farms (BOBE) - FREE Research Report

Hicks Randall J who is President Of Be Restaurants at Bob Evans Farms sold 5,003 shares at $49.76 on March 18, 2014. Following this transaction, the President Of Be Restaurants owned 33,698 shares meaning that the stake was reduced by 12.93% with the 5,003-share transaction.

The shares most recently traded at $50.31, up $0.55, or 1.09% since the insider transaction. Historical insider transactions for Bob Evans Farms go as follows:

  • 12-Week # shares sold: 656
  • 24-Week # shares sold: 656

The average volume for Bob Evans Farms has been 330,700 shares per day over the past 30 days. Bob Evans Farms has a market cap of $1.2 billion and is part of the services sector and leisure industry. Shares are down 2.69% year-to-date as of the close of trading on Tuesday.

Bob Evans Farms, Inc. owns and operates full-service restaurants under the Bob Evans brand name in the United States. It also sells retail gifts, food items, and other novelties in its Bob Evans restaurants, and 6 Bob Evans restaurants & general stores. The stock currently has a dividend yield of 2.55%. Currently there are 2 analysts that rate Bob Evans Farms a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BOBE - FREE

TheStreet Quant Ratings rates Bob Evans Farms as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, reasonable valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Bob Evans Farms Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Dow Fluctuates, Nasdaq Strikes Record High

Dow Fluctuates, Nasdaq Strikes Record High

Square Jumps After Price Target Is Raised

Square Jumps After Price Target Is Raised

Fed Chief Uncertain About Policy-Making as Unemployment Hits 18-Year Low

Fed Chief Uncertain About Policy-Making as Unemployment Hits 18-Year Low

Jim Cramer: Oil Needs to Go Down to See Worldwide Growth Pick Up

Jim Cramer: Oil Needs to Go Down to See Worldwide Growth Pick Up

Jim Cramer on the Problem With the Case for More Rate Hikes

Jim Cramer on the Problem With the Case for More Rate Hikes